Category Archives: CONRAD

  1. Meet Annette Larkin, A Friendly Rectal Microbicide Advocate

    Check out this interesting mini-bio of  Annette Larkin, the latest in IRMA’s “Meet a Friendly Rectal Microbicide Advocate” series on the IRMA website here.  Annette is one of five new bios posted last week. Annette LarkinAlexandria, Virginia, USA “It’s possible that microcides will really find a home in the rectum, so to speak.” Annette is an IRMA advocate, Read More >>

    advocacy, anal sex, CONRAD, Meet a Friendly Rectal Microbicide Advocate, new prevention technologies, rectal microbicide, research, Tenofovir
  2. FDA to Fast Track 1% Tenofovir (Press Release)

    Press Release from CONRAD October 25, 2010, Arlington, VA – – The U.S. Food and Drug Administration (FDA) held an end-of-Phase II meeting to determine the next steps required for U.S. licensure of 1% tenofovir gel, a microbicide product recently found to be effective at  reducing the rate of HIV and herpes infection in women when used Read More >>

    CAPRISA, CONRAD, FDA, IPM, Tenofovir
  3. NEW Rectal Microbicide Trial is Recruiting

    Official Title: “A Two-site, Phase 1, Partially-blinded, Placebo-controlled Safety, Acceptability and Pharmacokinetic Trial of Topical, Vaginally-formulated Tenofovir 1% Gel Applied Rectally Compared With Oral 300 mg Tenofovir Disoproxil Fumarate in HIV-1 Seronegative Adults” Clinical Trial Phase: Phase 1 | Start Date: September 2009 Overall Status: Recruiting Estimated Enrollment: 18 To date, the majority of microbicide research has Read More >>

    anal sex, CONRAD, Dr. Peter Anton, gay men, MSM, new prevention technologies, NIH, rectal microbicide, research, Tenofovir, women